Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL)

被引:0
|
作者
Piekarz, Richard [1 ]
Wright, John [2 ]
Frye, Robin [1 ]
Allen, Steven L. [3 ]
Craig, Michael [4 ]
Geskin, Larisa [5 ]
Hutchins, Laura [6 ]
Joske, David [7 ]
Kirschbaum, Mark [8 ]
Leonard, John P. [9 ]
Prince, Miles [10 ]
Reeder, Craig B. [11 ]
Jaffe, Elaine [1 ]
Bates, Susan [12 ]
机构
[1] NCI, Bethesda, MD 20892 USA
[2] IDB CTEP NCI, Rockville, MD USA
[3] N Shore Univ, Hosp LIJ, Lake Success, NY USA
[4] Mary Babb Randolph Canc Ctr, Morgantown, WV USA
[5] Univ Pittsburgh, Pittsburgh, PA USA
[6] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[7] Sir Charles Gairdner Hosp, Haematol Care Ctr, Perth, WA, Australia
[8] City Hope Natl Med Ctr, Div Hematol, Duarte, CA 91010 USA
[9] Weill Cornell Med Coll, New York, NY USA
[10] Peter MacCallum Canc Inst, Melbourne, Australia
[11] Mayo Clin Arizona, Scottsdale, AZ USA
[12] NCI, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:555 / 556
页数:2
相关论文
共 50 条
  • [1] Final Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL).
    Piekarz, Richard
    Wright, John
    Frye, Robin
    Allen, Steven L.
    Joske, David
    Kirschbaum, Mark
    Lewis, Ian D.
    Prince, Miles
    Smith, Sonali
    Jaffe, Elaine S.
    Bates, Susan
    BLOOD, 2009, 114 (22) : 661 - 662
  • [2] Multicenter phase II study of romidepsin plus lenalidomide for patients with previously untreated peripheral T-cell lymphoma (PTCL).
    Ruan, Jia
    Zain, Jasmine M.
    Palmer, Brett
    Jovanovic, Borko
    Mi, Xinlei
    Swaroop, Alok
    Winter, Jane
    Gordon, Leo I.
    Karmali, Reem
    Pro, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Ogura, Michinori
    Maruyama, Dai
    Tobinai, Kensei
    Uchida, Toshiki
    Hatake, Kiyohiko
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Tsukasaki, Kunihiro
    Ishida, Takashi
    Kobayashi, Naoki
    Ishizawa, Kenichi
    Tatsumi, Yoichi
    Kato, Koji
    Kiguchi, Toru
    Ikezoe, Takayuki
    Laille, Eric
    Ro, Tokihiro
    Tamakoshi, Hiromi
    Sakurai, Sanae
    Ohtsu, Tomoko
    BLOOD, 2016, 128 (22)
  • [4] PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
    O'Connor, O.
    Pro, B.
    Pinter-Brown, L.
    Popplewell, L.
    Bartlett, N.
    Lechowicz, M.
    Savage, K.
    Coiffier, B.
    Saunders, M.
    Horwitz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Phase 1/2 study of forodesine in patients with relapsed peripheral t-cell lymphoma (PTCL).
    Tsukasaki, Kunihiro
    Tobinai, Kensei
    Uchida, Toshiki
    Maeda, Yoshinobu
    Shibayama, Hirohiko
    Nagai, Hirokazu
    Kurosawa, Mitsutoshi
    Abe, Yasunobu
    Hatake, Kiyohiko
    Ando, Kiyoshi
    Yoshida, Isao
    Hidaka, Michihiro
    Murayama, Tohru
    Okitsu, Yoko
    Tsukamoto, Norifumi
    Taniwaki, Masafumi
    Suzumiya, Junji
    Tamura, Kazuo
    Yamauchi, Takahiro
    Ueda, Ryuzo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei R.
    Nichols, Jean
    Carroll, Susan
    Balser, John
    Horwitz, Steven M.
    BLOOD, 2011, 118 (21) : 272 - 272
  • [7] COMPLETE RESPONSES (CR/CRU) ON A PHASE 2 STUDY OF ROMIDEPSIN IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (R/R PTCL)
    Pro, B.
    Horwitz, S.
    Foss, F.
    Prince, M.
    Sokol, L.
    Greenwood, M.
    Caballero, D.
    Borchmann, P.
    Nichols, J.
    Balser, J.
    Carroll, S.
    Coiffier, B.
    ANNALS OF ONCOLOGY, 2011, 22 : 201 - 202
  • [8] Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei
    Nichols, Jean
    Carroll, Susan
    Balser, John
    Horwitz, Steven M.
    BLOOD, 2010, 116 (21) : 56 - 57
  • [9] Responses to romidepsin by line of therapy in patients with relapsed/refractory (R/R) peripheral T-cell lymphoma (PTCL).
    Foss, Francine M.
    Pro, Barbara
    Prince, H. Miles
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Horwitz, Steven M.
    Coiffier, Bertrand
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
    Maeda, Yoshinobu
    Tobinai, Kensei
    Nagai, Hirokazu
    Nakane, Takahiko
    Shimoyama, Tatsu
    Nakazato, Tomonori
    Sakai, Rika
    Ishikawa, Takayuki
    Izutsu, Koji
    Ueda, Ryuzo
    BLOOD, 2016, 128 (22)